Clinical study of Absorbable Bone Wax in Neurological Surgery
Phase 1
Completed
- Conditions
- The ability of new absorbable bone wax in stopping bone bleeding during craniotomy or craniectomy will be evaluated together with the handling properties.
- Registration Number
- TCTR20151116003
- Lead Sponsor
- ational Science and Technology Development Agency
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
•Patients who undergo general brain surgery.
•Patients who undergo craniotomy or craniectomy or skull surgery which create burr hole.
•Patients who have clean wound.
Exclusion Criteria
•Patients who have skull infection or osteomyelitis or inflammation
•Patients who have blood chemistry which indicated the inflammation i.e higher than normal values of WBC, ESR.
•Patients who have opened wound.
•Patients who have renal insufficiency or renal failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemostasis performance of absorable bone wax Intraoperative Observation
- Secondary Outcome Measures
Name Time Method Handling properties of absorbable bone wax Intraoperative Manually by hand